chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Immediate post-injection reaction, Injection site pain, Pain, Pain in extremity, Paraesthesia
Clinical narrative: When giving the injection, patient immediately felt pain which she stated spread down her arm to her hand and felt tingly. She was still able to move her hand, but the pain/tingly feeling persisted for about 20 minutes or so while in the store.  I called her back to follow up about 3 and a half hour later and she said her arm is feeling much better from before.  She still has some pain/tingly feeling remaining, but much less than a few hours prior.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse effect. PT given monovalent instead of intended bivalent.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: none known, pediatric dose given
Age: 41.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, Injection site discharge, Needle issue
Clinical narrative: Nurse stated the vaccine leaked out from the needle/patient's arm as soon as she started the ID dose in the left arm; patient did not receive the full dose. The same nurse administered another ID dose in the left arm (same arm) successfully.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was accidently given Pfizer monovalent instead of Bivalent. patient was informed of the administered  vaccine . no reported adverse events.
Age: 1.0
Sex: M
Vaccine: COVID19, FLU4, HEPA, MMR, VARCEL
Symptoms: Interchange of vaccine products
Clinical narrative: CMA accidentally administered Pfizer as second dose in COVID vaccine series when patient received Moderna as first dose.  First dose of Moderna vaccine administered on 7/23/22
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ataxia, Dysstasia, Gait inability
Clinical narrative: Severe ataxia to the extent patient was unable to walk or stand up without assistance.  Evaluated at a local Medical Center where code stroke was called, cardiac and infectious evaluation were done.  No cause of his ataxia was found.  Patient returned to baseline function after another 24 hours.
Age: 61.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt received high dose vaccine inappropriately based on age.  Should have received regular vaccine.
Age: 28.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt made appointment online and filled out paperwork online for Pfizer CoVid Bivalent shot.   When pt arrived to pharmacy, the tech at data entry asked if she was here for the Covid shot and processed the bivalent like her form said.   The immunization certified tech pulled up vaccine and had pharmacist verify she had done it correctly.   She then proceeded to give the shot.   After immunization was given, pt then asked if she comes back in 3 weeks for her second dose.   That is when it was discovered that pt had never received Covid vaccine before and should have been given the primary series.   The pharmacist then talked to pt and let her know that she may develop a higher immune response and advised her to drink plenty of water and take Tylenol for fever.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Chills, Headache, Lethargy, Pain
Clinical narrative: Very mild headache, infrequent mild chills, aching in extremities of the toes, heel of right foot, shoulders, and middle of body around the waist and hips lasting for 7 hours quite intensely, then tapering off quickly. The next morning still had very mild headache and lethargic all day long.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: Very mild headache, infrequent mild chills, aching in extremities of the toes, heel of right foot, shoulders, and middle of body around the waist and hips lasting for 7 hours quite intensely, then tapering off quickly. The next morning still had very mild headache and lethargic all day long.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was accidently given Pfizer monovalent instead of Bivalent. patient was informed of the administered  vaccine . no reported adverse events.
Age: 42.0
Sex: F
Vaccine: FLUC4
Symptoms: Asthenia, Cold sweat, Diarrhoea, Dizziness, Dysstasia
Clinical narrative: Dizziness, weakness, sweating yet clammy, loss of color in face,  nausea, diarhhea, trouble focusing eyes, trouble standing and walking without assistance
Age: 42.0
Sex: F
Vaccine: FLUC4
Symptoms: Gait disturbance, Hyperhidrosis, Nausea, Pallor, Vision blurred
Clinical narrative: Dizziness, weakness, sweating yet clammy, loss of color in face,  nausea, diarhhea, trouble focusing eyes, trouble standing and walking without assistance
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was accidently given Pfizer monovalent instead of Bivalent. patient was informed of the administered  vaccine . no reported adverse events.
Age: 63.0
Sex: F
Vaccine: FLU4, MMR
Symptoms: Incorrect route of product administration
Clinical narrative: The MMR was administered via intramuscular injection in the left deltoid.  The error was realized within 1 hour of administration and the patient immediately notified.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site warmth
Clinical narrative: 2 days after the injection, patient states red, warm, painful rash below the injection site.
Age: 51.0
Sex: F
Vaccine: COVID19-2, FLUR4
Symptoms: Balance disorder, Dizziness, Fall, Injection site haemorrhage
Clinical narrative: Patient felt dizzy after seeing a small amount of blood at the injection site. She was advised to sit down for 10 to 15 minutes. After a few minutes the patient got up and tried to go to her car to wait it out, but lost her balance and went to her knees. We brought her a chair and gave her water. She was feeling better after a few minutes but had her husband pick her up so she didn't have to drive.
Age: 68.0
Sex: F
Vaccine: UNK
Symptoms: Asthenia, Cough, Decreased appetite, Feeling abnormal, Feeling cold
Clinical narrative: Sweating, freezing cold, chronic thirst, sore throat headaches fuzzy brain weakness loss of appetite cough.
Age: 68.0
Sex: F
Vaccine: UNK
Symptoms: Headache, Hyperhidrosis, Oropharyngeal pain, Thirst
Clinical narrative: Sweating, freezing cold, chronic thirst, sore throat headaches fuzzy brain weakness loss of appetite cough.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Mastitis, Suppressed lactation
Clinical narrative: 9/7/22- current: Large decrease in milk production 9/13/22:Mastitis L breast- antibiotics prescribed by lactation provider 9/30/22: Mastitis R breast- antibiotics prescribed and see in ED
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site swelling, Lymphadenopathy, Migraine
Clinical narrative: Swollen lymph nodes in armpit on arm of shot, fatigue, chills, fever, nausea, migraine, swollen arm at site of injection,
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Swollen lymph nodes in armpit on arm of shot, fatigue, chills, fever, nausea, migraine, swollen arm at site of injection,
Age: 72.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired Flu Vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 10.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: I took my child into for a Flu Shot but she was administered a COVID Shot Booster which is not FDA approved for her age of pediatric patients.
Age: 10.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Wrong product administered
Clinical narrative: I took my child into for a Flu Shot but she was administered a COVID Shot Booster which is not FDA approved for her age of pediatric patients.
Age: 53.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Eye pain, Fatigue, Malaise, Migraine
Clinical narrative: Felt sick after the day. On Thursday I woke up with sever chills and night sweats. The morning of I woke up with eye pain it?s been 2 weeks now. Went to urgent care and the ER they think the booster triggered migraines. But I still have chills and sweats and feel like I have a fever. Super tired
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Night sweats, Pyrexia
Clinical narrative: Felt sick after the day. On Thursday I woke up with sever chills and night sweats. The morning of I woke up with eye pain it?s been 2 weeks now. Went to urgent care and the ER they think the booster triggered migraines. But I still have chills and sweats and feel like I have a fever. Super tired
Age: 29.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 16.0
Sex: F
Vaccine: FLU4
Symptoms: Loss of consciousness, Skin discolouration
Clinical narrative: Patient, female , brought into pharmacy to receive Fluzone Quad, one immunization, cosigned by Mom and was given immunization by myself.    Used appropriate needle and vaccine,  and patient seemed fine for a minute, was walking out of booth toward mom and her sister.   Mom said " do you want a new bandaid?"  and I offered to change the bandaid and when starting to put new on on skin , the patient passed out in the booth.   The mom immediately rushed to the patient (daughter) and held her head and brought her back by talking to her and moving her head.   A  fire fighter in line at the pharmacy rushed over also, and a nurse who knew the mom.   All three assisted the patient ,and within  a few minutes she had her color back and could respond in about five minutes.   Mom stayed on top of her daughter.   The mom said "she has low blood sugar, and never has seizures, and has had flu vaccines in the past , with no problems.   The EMR came to check her out, but mom took her home.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Dizziness, Eye irritation, Fatigue, Gait disturbance
Clinical narrative: Not sure if this is an adverse reaction, but I don't know what I've got.  But it is an immune response to something:  joints and muscles painful - must walk slow, headache, slight fever (100F), burning eyes, swelling lips, some dizziness, exhaustion, swollen left lymph node in left neck under jaw.  Took 2 COVID tests that were negative.  Woke up in middle of night last night totally soaked (sweating off something ? yuk!), but then I felt better this morning, but by the afternoon I'm dragging again. Did not go to Dr.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Hyperhidrosis, Immune system disorder, Lethargy, Lip swelling
Clinical narrative: Not sure if this is an adverse reaction, but I don't know what I've got.  But it is an immune response to something:  joints and muscles painful - must walk slow, headache, slight fever (100F), burning eyes, swelling lips, some dizziness, exhaustion, swollen left lymph node in left neck under jaw.  Took 2 COVID tests that were negative.  Woke up in middle of night last night totally soaked (sweating off something ? yuk!), but then I felt better this morning, but by the afternoon I'm dragging again. Did not go to Dr.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymphadenopathy, Myalgia, Night sweats, SARS-CoV-2 test negative, Sleep disorder
Clinical narrative: Not sure if this is an adverse reaction, but I don't know what I've got.  But it is an immune response to something:  joints and muscles painful - must walk slow, headache, slight fever (100F), burning eyes, swelling lips, some dizziness, exhaustion, swollen left lymph node in left neck under jaw.  Took 2 COVID tests that were negative.  Woke up in middle of night last night totally soaked (sweating off something ? yuk!), but then I felt better this morning, but by the afternoon I'm dragging again. Did not go to Dr.
Age: 56.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood test abnormal, Loss of personal independence in daily activities, Pain, Pain in extremity
Clinical narrative: Pain started in your arms down to my wrists and hands, across my back and the back of my legs. The pain also went to my wrist where I had an old injury years before.  Approximately 2 weeks after the second dose of Pfizer vaccine,  I could not get my shirt off without help. I was put on steroids; I have been on them for almost a year. I still have the pain in my wrists and hands. Burning and numbing, pulsating pain. I just stopped taking the steroids.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Polymyalgia rheumatica
Clinical narrative: Pain started in your arms down to my wrists and hands, across my back and the back of my legs. The pain also went to my wrist where I had an old injury years before.  Approximately 2 weeks after the second dose of Pfizer vaccine,  I could not get my shirt off without help. I was put on steroids; I have been on them for almost a year. I still have the pain in my wrists and hands. Burning and numbing, pulsating pain. I just stopped taking the steroids.
Age: 58.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 41.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 48.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 45.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse event. Received Bivalent booster as 1st dose. Has not received primary series yet.
Age: 44.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 30.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 39.0
Sex: M
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Gingival pain, Headache, Muscle tightness, Pain in jaw, Pain of skin
Clinical narrative: Ten days after receiving the covid booster, I began experiencing swelling in the back of my neck, and in the right side of my face, including my cheek, jaw, sinus (right side of my nose under the eye) , gums, right roof of my mouth, right inner ear, and scalp/head near my ear. This sweling has resulted in pain and tightness in my right jaw, teeth, and gum and scalp tenderness on the right side, and generalized headache on the right side.  Also the swollen areas are warmer to the touch. I have been self-treating the pain/swelling with ibuprofen, acetominophen, and sometimes benedryl.  I have also been applying cold compress or an ice pack to my face and neck.  This is now the fifth consecutive day of these symptoms.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Skin warm, Swelling, Toothache
Clinical narrative: Ten days after receiving the covid booster, I began experiencing swelling in the back of my neck, and in the right side of my face, including my cheek, jaw, sinus (right side of my nose under the eye) , gums, right roof of my mouth, right inner ear, and scalp/head near my ear. This sweling has resulted in pain and tightness in my right jaw, teeth, and gum and scalp tenderness on the right side, and generalized headache on the right side.  Also the swollen areas are warmer to the touch. I have been self-treating the pain/swelling with ibuprofen, acetominophen, and sometimes benedryl.  I have also been applying cold compress or an ice pack to my face and neck.  This is now the fifth consecutive day of these symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site discomfort, Injection site erythema, Injection site pruritus, Injection site warmth, Pain in extremity
Clinical narrative: Vaccinate on Sept 27. Arm sore within 16 hours. Discomfort (itching, heat) accompanied by redness spreading in size to an area of about 4" by 3" by Sept 30 at the injection site.  Reported this reaction by phone to PCP on Sept 30.  Heat is an unusual side effect of an injection for me, although a bit of soreness is not. Such a large sized red patch reminds me of a tick bite, but this redness is oddly rectangular-not round as a tick bite might be.  Discomfort somewhat reduced by cool, damp compresses, naproxen and diphenhydramine (50 mg). Called primary care provider to report symptoms.
Age: 61.0
Sex: F
Vaccine: UNK
Symptoms: Peripheral swelling
Clinical narrative: my arm had swelled up  very large the first day of the shot, as of today the swellness has not decrease. My Dr. insist that I take warm baths and use a heating bad everyday.
Age: 27.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Injection site rash, Pyrexia
Clinical narrative: Fever, rash on right arm at site of Covid booster
Age: 64.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 12.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Cold sweat, Head titubation, Lethargy, Malaise, Pallor
Clinical narrative: Boostrix administered first. Then Varivax.  Was talking to mom and patient, and patient said she didn't feel well, then head fell back (in chair) - she fainted. She came to quickly, but was pale, clammy and lethargic. Paramedics and Fire Department arrived shortly after, evaluated her vitals, watched her for a while, and advised mom it looked like she fainted, and was looking more back to normal.
Age: 12.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Syncope
Clinical narrative: Boostrix administered first. Then Varivax.  Was talking to mom and patient, and patient said she didn't feel well, then head fell back (in chair) - she fainted. She came to quickly, but was pale, clammy and lethargic. Paramedics and Fire Department arrived shortly after, evaluated her vitals, watched her for a while, and advised mom it looked like she fainted, and was looking more back to normal.
Age: 38.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 43.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Malaise
Clinical narrative: Fatigue, general malaise, chills-onset within 2 hours of getting the vaccine. Lasting at least two days. Treatment: rest and Tylenol
Age: 51.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Malaise, Nausea
Clinical narrative: Chills, general malaise, nausea, sweats. 7 a.m. to 7 p.m.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I have not yet been able to contact the patient. I am not aware of any symptoms, just that the vaccine was accidently given early (46 days from last dose instead of 2 months).
Age: 37.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 39.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 47.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 73.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 35.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 44.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 49.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Papule, Rash papular
Clinical narrative: Rash on left deltoid at injection site that developed approximately 2 weeks after administration.  Rash is collection of about 8-10 raised flesh colored papules of 1-2mm in diameter.  Not painful or itchy.  Patient is not bothered by the rash. Skin surrounding the rash is normal.  No vesicles, blistering or crusting.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Cough, Fatigue, Headache, Nausea
Clinical narrative: Headache, chills, coughing, fatigue, nausea, excessive urination.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pollakiuria
Clinical narrative: Headache, chills, coughing, fatigue, nausea, excessive urination.
Age: 33.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 57.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Swelling face
Clinical narrative: Patient developed swelling and puffiness on the right lower cheek
Age: 50.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 66.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 32.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 40.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 75.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 46.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 52.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Expired flu vaccine. The patient was re-evaluated, and no complaints were voiced.
Age: 20.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Wrong product administered
Clinical narrative: none. Patient received bivalent COVID vaccine instead of (grey cap) COVID vaccine dose #1.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, TDAP
Symptoms: Central nervous system lesion, Demyelination, Hemiplegia, Inappropriate schedule of product administration, Laboratory test
Clinical narrative: Approx 3 days post second Pfizer vaccine experienced paralysis on (L) side - could not hold pencil. Went to ER x3 visits - went to primary MD - had MRI brain showing lesions, demyelinization process. Admitted for high dose steroid therapy - dx with MS. First MS - NO History! No family HX.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, TDAP
Symptoms: Loss of personal independence in daily activities, Magnetic resonance imaging head abnormal, Multiple sclerosis
Clinical narrative: Approx 3 days post second Pfizer vaccine experienced paralysis on (L) side - could not hold pencil. Went to ER x3 visits - went to primary MD - had MRI brain showing lesions, demyelinization process. Admitted for high dose steroid therapy - dx with MS. First MS - NO History! No family HX.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Poor quality product administered, Product preparation error
Clinical narrative: Invalid dose due to incorrect diluent used while drawing up the vaccine. No adverse events. patient must come back to office for repeat dose per our immunization coordinator who spoke with the state. patient was called and was made aware of the situation by primary care Dr. patient is scheduled to come back to the office on 10/03/2022 for repeat vaccine.
Sex: U
Vaccine: UNK
Symptoms: Recalled product administered
Clinical narrative: Booster vaccines given after authorization revoked with the new bivalent vaccine. see attachment
Age: 28.0
Sex: F
Vaccine: MENB
Symptoms: Lip swelling, Swelling face, Swollen tongue, Wheezing
Clinical narrative: Narrative: she received both the influenza and the meningococcal b in her arm earlier on 9/27 @ 1100. She woke up at -0230 on 9/28 with facial and lip swelling that resolved on its own while in the ED. She subsequently declined observation at the ED. She subsequently declined observation at the ED and went home where she took a dose of diphenhydramine and went back to sleep. She woke up at 0700 9/28 w/complaints of wheezing and lip and tongue swelling. ED provider states she does seem to have L jaw swelling, as similarly noted at ER.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt had received two covid vaccine EUA (J&J) on 4/2/2021 and 11/10/2021 at location. Pt died at community hospital on 9/15/2022. No information is available regarding circumstances of this death. Likely the vaccines were not the cause of this patient's death given the long length of time between date of vaccines given & date of death.
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Contusion, Fall, Laboratory test, Petechiae
Clinical narrative: Patient presented to the clinic, 12 days after immunization, stating patient had bruises on the left face after falling down, the day before. This morning noticed more bruises on legs, arms, trunk & came to MD office, who noticed petechiae & sent pt to hospital.
Age: 91.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombocytopenia
Clinical narrative: Narrative:  Per CPRS info from reporter: "per patient, thrombocytopenia happened with booster in 10/2021. Admitted to outside hospital with severe thrombocytopenia"
Age: 90.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 53.0
Sex: M
Vaccine: TDAP
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Sex: U
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: COVID #3 Booster Provided to Age > 12 + with no SE or ill Effect to 8-10 pediatric Adolescent patients.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Swelling face
Clinical narrative: Narrative:  Multiple ER visits (both to his local community ER and other ER) over a series of days - due to continued facial swelling, difficulty breathing. Provided both a steroid shot at local ER on 6/11/22 and then Medrol Dose pack on 6/13/22. This orginated with the other ER. It was suggested that patient take oral Benadryl.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Blood test, Change in sustained attention, Electroencephalogram, Laboratory test, Magnetic resonance imaging
Clinical narrative: Mother reports symptoms started Approx 3 weeks ago. Suffering 4 episodes of seizure-like activities per day. Patient knows that episode is going to come on. Patient has body shaking and eyes focus on one object. This patient was seen at Hospital and referred to pediatric neurology.  Patient had bloodwork and EEG/MRI. Patient places on Keppra.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Seizure like phenomena, Tremor
Clinical narrative: Mother reports symptoms started Approx 3 weeks ago. Suffering 4 episodes of seizure-like activities per day. Patient knows that episode is going to come on. Patient has body shaking and eyes focus on one object. This patient was seen at Hospital and referred to pediatric neurology.  Patient had bloodwork and EEG/MRI. Patient places on Keppra.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Paraesthesia
Clinical narrative: Tingling (pins and needles) in injected arm  (Please note that it is hard to read the lot number as written on vacc record. I believe that the second letter is an 5. I tried to enter this in the space below, but the webpage didn't permit it.)
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site hypersensitivity, Injection site pain, Injection site swelling, Injection site warmth, Ultrasound scan
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test, Vaccination failure
Clinical narrative: clay colored stools; loose stools; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 25Apr2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 71 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Pre DM" (unspecified if ongoing), notes: Pre DM; "Lung disease/interstitial screening from prior toxic exposure" (unspecified if ongoing), notes: Lung disease (please specify) interstitial screening from prior toxic exposure.; "NAFLD" (unspecified if ongoing), notes: NAFLD; "oxalate stones" (unspecified if ongoing), notes: Kidney disease (please specify) oxalate stones.; "familial hyperlipidemia" (unspecified if ongoing); "Gout" (unspecified if ongoing); "Is the patient a smoker/ former smoke? No" (unspecified if ongoing), notes: Is the patient a smoker/ former smoke? No. Concomitant medication(s) included: TENORMIN; SYNTHROID; NORVASC; CLONIDINE; LOSARTAN; POTASSIUM CITRATE; VITAMIN D3. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EN6201; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 12Feb2021, when the patient was 70-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6198; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 05Mar2021, when the patient was 70-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: FF2593; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 23Oct2021, when the patient was 71-year-old, for COVID-19 Immunization. The following information was reported: FAECES PALE (non-serious) with onset 2022, outcome "unknown", described as "clay colored stools"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "loose stools".  Additional information: Patient was not hospitalized or admitted to an Intensive Care Unit. Patient was not still (at the time of this report) hospitalized. Patient did not display clinical signs at rest indicative of severe systemic illness and did not require supplemental oxygen (including high flow or ECMO) or received mechanical ventilation. New or worsened symptoms/signs during the COVID-19 illness included clay-colored stools and loose stools.  Follow-up attempts are completed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Faeces pale
Clinical narrative: clay colored stools; loose stools; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 25Apr2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 71 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Pre DM" (unspecified if ongoing), notes: Pre DM; "Lung disease/interstitial screening from prior toxic exposure" (unspecified if ongoing), notes: Lung disease (please specify) interstitial screening from prior toxic exposure.; "NAFLD" (unspecified if ongoing), notes: NAFLD; "oxalate stones" (unspecified if ongoing), notes: Kidney disease (please specify) oxalate stones.; "familial hyperlipidemia" (unspecified if ongoing); "Gout" (unspecified if ongoing); "Is the patient a smoker/ former smoke? No" (unspecified if ongoing), notes: Is the patient a smoker/ former smoke? No. Concomitant medication(s) included: TENORMIN; SYNTHROID; NORVASC; CLONIDINE; LOSARTAN; POTASSIUM CITRATE; VITAMIN D3. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EN6201; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 12Feb2021, when the patient was 70-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6198; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 05Mar2021, when the patient was 70-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: FF2593; Route of administration: Intramuscular; Site of injection: Left arm), administration date: 23Oct2021, when the patient was 71-year-old, for COVID-19 Immunization. The following information was reported: FAECES PALE (non-serious) with onset 2022, outcome "unknown", described as "clay colored stools"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "loose stools".  Additional information: Patient was not hospitalized or admitted to an Intensive Care Unit. Patient was not still (at the time of this report) hospitalized. Patient did not display clinical signs at rest indicative of severe systemic illness and did not require supplemental oxygen (including high flow or ECMO) or received mechanical ventilation. New or worsened symptoms/signs during the COVID-19 illness included clay-colored stools and loose stools.  Follow-up attempts are completed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse event; accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago) and NO ADVERSE EVENT (No adverse event) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Sep-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago).    No concomitant medications were provided by the reporter.  Reporter accidently gave a  bivalent booster of Pfizer COVID-19 vaccine on 25-SEP-2022 at 4 PM with lot number GH9702 on right deltoid to a patient. However, patient had only received 1 dose of Moderna 1 year ago.  It was reported that patient had no harm.  No treatment medications were provided by the reporter.
Age: 22.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago) and NO ADVERSE EVENT (No adverse event) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Sep-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave a bivalent booster to someone that only received 1 dose of Moderna 1 year ago).    No concomitant medications were provided by the reporter.  Reporter accidently gave a  bivalent booster of Pfizer COVID-19 vaccine on 25-SEP-2022 at 4 PM with lot number GH9702 on right deltoid to a patient. However, patient had only received 1 dose of Moderna 1 year ago.  It was reported that patient had no harm.  No treatment medications were provided by the reporter.
Age: 71.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Laboratory test, Urticaria
Clinical narrative: Hives; Restless night; Low fever; Itchiness on site of injection; Flu like symptoms; Cramps; Diahrrea; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and POOR QUALITY SLEEP (Restless night) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7165B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (ACE inhibitor) and Drug allergy (Moxifloxacin). Concomitant products included FAMOTIDINE, ROSUVASTATIN, HYDROCHLOROTHIAZIDE, AMLODIPINE, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and BISACODYL (DULCOLAX [BISACODYL]) for an unknown indication.  On 22-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Sep-2022, the patient experienced VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever). On 27-Sep-2022, the patient experienced POOR QUALITY SLEEP (Restless night). On 28-Sep-2022, the patient experienced URTICARIA (Hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at a dose of during the day; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at a dose of at night and TRIAMCINOLONE for Hives, at a dose of UNK, bid. On 23-Sep-2022, VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever) had resolved. At the time of the report, POOR QUALITY SLEEP (Restless night) and URTICARIA (Hives) outcome was unknown.      Patient received 4 doses of the Moderna COVID-19 vaccine by unknown route on 29-Jan-2021 (lot number 02AL20A) first dose, On 26-Feb-2021 (lot number 0L0A21A) second dose, On 08-Nov-2021 (lot number 039F21A) 1st Booster Dose, and  On 06-May-2022 (lot number 056A22) 2nd Booster.
Age: 71.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Diarrhoea, Influenza like illness, Muscle spasms, Poor quality sleep, Pyrexia
Clinical narrative: Hives; Restless night; Low fever; Itchiness on site of injection; Flu like symptoms; Cramps; Diahrrea; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and POOR QUALITY SLEEP (Restless night) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7165B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (ACE inhibitor) and Drug allergy (Moxifloxacin). Concomitant products included FAMOTIDINE, ROSUVASTATIN, HYDROCHLOROTHIAZIDE, AMLODIPINE, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and BISACODYL (DULCOLAX [BISACODYL]) for an unknown indication.  On 22-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Sep-2022, the patient experienced VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever). On 27-Sep-2022, the patient experienced POOR QUALITY SLEEP (Restless night). On 28-Sep-2022, the patient experienced URTICARIA (Hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at a dose of during the day; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at a dose of at night and TRIAMCINOLONE for Hives, at a dose of UNK, bid. On 23-Sep-2022, VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever) had resolved. At the time of the report, POOR QUALITY SLEEP (Restless night) and URTICARIA (Hives) outcome was unknown.      Patient received 4 doses of the Moderna COVID-19 vaccine by unknown route on 29-Jan-2021 (lot number 02AL20A) first dose, On 26-Feb-2021 (lot number 0L0A21A) second dose, On 08-Nov-2021 (lot number 039F21A) 1st Booster Dose, and  On 06-May-2022 (lot number 056A22) 2nd Booster.
Age: 71.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Urticaria, Vaccination site pruritus
Clinical narrative: Hives; Restless night; Low fever; Itchiness on site of injection; Flu like symptoms; Cramps; Diahrrea; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and POOR QUALITY SLEEP (Restless night) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7165B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (ACE inhibitor) and Drug allergy (Moxifloxacin). Concomitant products included FAMOTIDINE, ROSUVASTATIN, HYDROCHLOROTHIAZIDE, AMLODIPINE, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and BISACODYL (DULCOLAX [BISACODYL]) for an unknown indication.  On 22-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Sep-2022, the patient experienced VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever). On 27-Sep-2022, the patient experienced POOR QUALITY SLEEP (Restless night). On 28-Sep-2022, the patient experienced URTICARIA (Hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at a dose of during the day; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at a dose of at night and TRIAMCINOLONE for Hives, at a dose of UNK, bid. On 23-Sep-2022, VACCINATION SITE PRURITUS (Itchiness on site of injection), INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramps), DIARRHOEA (Diahrrea) and PYREXIA (Low fever) had resolved. At the time of the report, POOR QUALITY SLEEP (Restless night) and URTICARIA (Hives) outcome was unknown.      Patient received 4 doses of the Moderna COVID-19 vaccine by unknown route on 29-Jan-2021 (lot number 02AL20A) first dose, On 26-Feb-2021 (lot number 0L0A21A) second dose, On 08-Nov-2021 (lot number 039F21A) 1st Booster Dose, and  On 06-May-2022 (lot number 056A22) 2nd Booster.
Age: 89.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site reaction, Musculoskeletal stiffness, Pain, Pain in extremity
Clinical narrative: Patient experienced arm pain and stiffness in the left shoulder, radiating down the left arm, and in the 4th & 5th fingers. Started the day after immunization, remains unresolved. Pt was treated with Prednisone by his physician approximately 1 month ago - treatment was unsuccessful.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Heart rate increased, Pain in extremity
Clinical narrative: Elevated heart rate and blood pressure for four whole days following vaccination. Resting heart rate reached as high as 130. Also elevated blood pressure when I have always had normal blood pressure. Sore arm for one day, the day after.
Age: 71.0
Sex: M
Vaccine: COVID19-2, PNC20
Symptoms: Blood test, Cardiac flutter, Cardiac stress test, Chest discomfort, Chest pain
Clinical narrative: Heart flutter, chest tightness and pain , irregular heartbeat  Myocarditis?